|
RNF11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.635400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.712010E-02 |
| Normal-vs-Stage2 |
2.640600E-01 |
| Normal-vs-Stage3 |
3.365000E-04 |
| Normal-vs-Stage4 |
1.72187999999407E-05 |
| Stage1-vs-Stage2 |
4.394200E-01 |
| Stage1-vs-Stage3 |
3.242400E-02 |
| Stage1-vs-Stage4 |
3.042900E-03 |
| Stage2-vs-Stage3 |
4.135600E-02 |
| Stage2-vs-Stage4 |
5.603700E-03 |
| Stage3-vs-Stage4 |
2.238800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.972200E-04 |
| Normal-vs-AfricanAmerican |
3.933400E-01 |
| Normal-vs-Asian |
5.755400E-03 |
| Caucasian-vs-AfricanAmerican |
1.426580E-01 |
| Caucasian-vs-Asian |
9.471000E-01 |
| AfricanAmerican-vs-Asian |
1.794440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.834820E-04 |
| Normal-vs-Female |
1.127780E-02 |
| Male-vs-Female |
3.888000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.436300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.203000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.650000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.807800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.083800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.660300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.181000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.932600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.738000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.671600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.656300E-03 |
| Classical-VS-Follicular |
2.770800E-01 |
| Classical-VS-Other |
4.054600E-01 |
| Classical-VS-Normal |
8.616500E-03 |
| Tall-VS-Follicular |
1.703260E-03 |
| Tall-VS-Other |
6.822200E-01 |
| Tall-VS-Normal |
4.16060000000273E-05 |
| Follicular-VS-Other |
2.962600E-01 |
| Follicular-VS-Normal |
2.047200E-01 |
| Other-VS-Normal |
7.417900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.074160E-02 |
| Normal-vs-N1 |
4.22669999999847E-05 |
| N0-vs-N1 |
1.792410E-02 |
|
|
